Brooksville, FL by Oak Hill Hospital
Current UCmedicationsinadequate?
You may qualify for a UC research study with no-cost testing and study medication in Brooksville.
Study led byDr. Salman MuddassirRated Top Physician — Consumer Research Council of America- No Insurance Needed
- No Cost
- Up to $150/Visit
- Transportation Provided
Quick eligibility check
See if you may qualify
What people say
“Wonderful people and great communication! I highly recommend them!”
“I was treated very well. Very Professional and very thorough. I highly recommend them...”
“They treat you like you matter”
General patient reviews about Access Research Institute — not claims about this study or its results.

Dr. Salman Muddassir
Principal Investigator
Internal Medicine
Dr. Muddassir leads this research at Access Research Institute, guiding you from your first conversation through every study visit.
Rated one of America’s Top Physicians by the Consumer Research Council of America.
Reviews your diagnosis, symptoms, and medication history with you
Answers every question about the study before you decide anything
Oversees your safety and care for the full length of the study
Could This Be For You?
- You're 18 to 80 years old
- You've been diagnosed with ulcerative colitis that is currently moderately to severely active
- At least one qualifying UC treatment did not help enough, stopped working, or caused side effects you could not tolerate
- You have not previously received Entyvio (vedolizumab) or another anti-integrin medicine
- You can attend study visits in Brooksville, FL
Other requirements apply. Our team can review them with you.
What Would I Actually Have to Do?
- 1
Answer 4 Quick Questions
Tell us about your UC, then share your contact details so our team can follow up.
- 2
Our Team Contacts You
A coordinator reviews your answers with you, asks any additional questions, and explains the study.
- 3
Decide Whether to Take the Next Step
If the study may be a match, our team will explain the screening visit. You decide whether to continue.
FAQ
This study is for adults ages 18 to 80 with moderately to severely active ulcerative colitis. A research coordinator will review your diagnosis, medical records, symptoms, and screening results with you.
Before starting vedolizumab, participants must have had an inadequate response, loss of response, or intolerance to at least one qualifying treatment, such as corticosteroids, an immunomodulator, or an advanced therapy. The study team will review the specific treatment requirements with you.
The protocol excludes people who have previously received vedolizumab (Entyvio) or another approved or investigational anti-integrin antibody. If you are unsure which medicines you have taken, a coordinator can review your medication history.
Do not stop or change any prescription medication on your own. The research team will review your medications and explain what is and is not permitted before you make any decision about participating.
Qualified participants may receive up to $150 for each completed study visit. A coordinator will explain the payment schedule before you decide whether to participate.
Transportation to and from study visits is available at no cost.
No. The online form only helps the research team determine whether it may be worth speaking with you.
A research coordinator will contact you, review a few additional questions, and explain the next steps.
